Subscribe to KPMG's Deal Capsule Life Sciences Newsletter
Preview of the KPMG Deal Capsule Life Sciences Newsletter
The new edition of our quarterly newsletter on transactions in the global life sciences industry glances back at the significant deals that took place in Q1-Q3 2021.
Life Sciences M&A activity continues its steady trend, already exceeding in Q3 2021 the previous full-year levels.
- Continuous momentum in biotech and medical devices & diagnostics subsectors drove life sciences M&A activity in Q1-Q3 2021.
- Focus of M&A activities was primarily on nutrition and healthcare, digitalization, robotic surgeries and novel therapeutics.